Growing Prevalence Of Neurological And Chronic Pain Conditions Fueling Demand For Gabapentin Market
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period.The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applicati...
New York United States Reddy Laboratories Ltd Teva Pharmaceutical Industries Ltd Hikma Pharmaceuticals Greater New York Chamber
Source: pharmiweb.com